Intellinetics
INLX
11 hedge funds and large institutions have $3.89M invested in Intellinetics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0.02% less ownership
Funds ownership: 7.68% → 7.66% (-0.02%)
7% less capital invested
Capital invested by funds: $4.17M → $3.89M (-$274K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$131K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$42.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$33K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.9K |
| 5 |
BlackRock
New York
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$3.11K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$246 |
INLX Hedge Fund Activity: Q3 2025 in Review
11 of the 7,645 institutional investors tracked by Wall St. Rank reported a position in Intellinetics (INLX) for Q3 2025, worth a combined $3.89M — down 6.6% from $4.17M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new INLX positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Cetera Investment Advisers, opening a new position worth an estimated $131K. The largest seller was Bard Associates, cutting an estimated $3.11K.
- 11 institutional investors held Intellinetics (INLX) as of Q3 2025, up from 9 in Q2 2025.
- Funds reported $3.89M of Intellinetics stock for Q3 2025, down 6.6% quarter-over-quarter.
- 3 funds opened new Intellinetics positions in Q3 2025 and 0 closed out, a net change of +3 holders.
- The largest Intellinetics buyer in Q3 2025 was Cetera Investment Advisers, an estimated $131K added.
- The largest Intellinetics seller in Q3 2025 was Bard Associates, an estimated $3.11K sold.
Based on aggregated 13F filings for Q3 2025.